PEAK6 Group’s Pulse Biosciences PLSE Stock Holding History

PEAK6 Group’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,582	Closed	-$85K	–	4640
2017 Q3	$85K	Buy	+4,582	New	+$104K	﹤0.01%	3824

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Group's PLSE Position: Q4 2017 in Review

PEAK6 Group sold out of Pulse Biosciences (PLSE) in Q4 2017, closing a stake of 4,582 shares — an estimated $85K sold.

PEAK6 Group first reported a position in PLSE in Q3 2017 and held it in 1 quarter. The position peaked at $85K in Q3 2017. 50 funds tracked by Wall St. Rank hold PLSE as of Q4 2017.

PEAK6 Group reported no remaining Pulse Biosciences position as of Q4 2017 after selling out during the quarter.
PEAK6 Group sold 4,582 Pulse Biosciences shares in Q4 2017, an estimated $85K.
PEAK6 Group first reported a position in Pulse Biosciences in Q3 2017 and held it in 1 quarter.
PEAK6 Group's Pulse Biosciences position peaked at $85K in Q3 2017.
50 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.